ArticleBioinformatics (Oxford, England)2025
scNucMap: mapping the nucleosome landscapes at single-cell resolution.
Article in Bioinformatics (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Nucleosome spacing across cell types, diseases, and ages.Nucleic acids research · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
motivationNucleosome depletion around cis-regulatory elements (CREs) is associated with CRE activity and implies the underlying gene regulatory network. Single-cell micrococcal nuclease sequencing (scMNase-seq) enables the simultaneous measurement of nucleosome positioning and chromatin accessibility at single-cell resolution, thereby capturing cellular heterogeneity in epigenetic regulation. However, there is currently no computational tool specifically designed to decode scMNase-seq data, impeding the generation of more precise and context-dependent insights into chromatin dynamics and gene regulation.
resultsHere, we present scNucMap, a tool designed to leverage the unique characteristics of scMNase-seq data to map the landscapes of candidate nucleosome-free regions (NFRs). scNucMap demonstrated superior performance and robustness in cell clustering on scMNase-seq data compared to Signac and chromVAR across diverse sample compositions and data complexities, achieving higher overall accuracy and Kappa coefficients. Additionally, scNucMap identified significant TFs associated with nucleosome depletion at CREs at both single-cell and cell-cluster levels, thereby facilitating cell-type annotation and regulatory network inference. When applied to scATAC-seq data, scNucMap enriched standard analyses with complementary insights into nucleosome architecture, underscoring its cross‑modality versatility. Overall, scNucMap exhibits both high reliability and adaptability, making it an effective tool for analyzing scMNase-seq data and supporting multimodal studies, thereby illuminating the intricate relationship between regulatory networks and nucleosome positioning at single-cell resolution. AVAILABILITY AND IMPLEMENTATION: scNucMap is available at https://github.com/qianming-bioinfo/scNucMap.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.